CVM
Price
$2.44
Change
-$2.07 (-45.90%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
410.58M
MGX
Price
$1.66
Change
+$0.01 (+0.61%)
Updated
May 22, 04:59 PM (EDT)
Capitalization
63.55M
83 days until earnings call
Interact to see
Advertisement

CVM vs MGX

Header iconCVM vs MGX Comparison
Open Charts CVM vs MGXBanner chart's image
Cel-Sci
Price$2.44
Change-$2.07 (-45.90%)
Volume$9.27K
Capitalization410.58M
Metagenomi
Price$1.66
Change+$0.01 (+0.61%)
Volume$1.48K
Capitalization63.55M
CVM vs MGX Comparison Chart
Loading...
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVM vs. MGX commentary
May 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVM is a Hold and MGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
May 23, 2025
Stock price -- (CVM: $4.51 vs. MGX: $1.65)
Brand notoriety: CVM: Notable vs. MGX: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVM: 27% vs. MGX: 81%
Market capitalization -- CVM: $410.58M vs. MGX: $63.55M
CVM [@Biotechnology] is valued at $410.58M. MGX’s [@Biotechnology] market capitalization is $63.55M. The market cap for tickers in the [@Biotechnology] industry ranges from $305.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVM’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • CVM’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, CVM is a better buy in the long-term than MGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVM’s TA Score shows that 6 TA indicator(s) are bullish while MGX’s TA Score has 6 bullish TA indicator(s).

  • CVM’s TA Score: 6 bullish, 4 bearish.
  • MGX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MGX is a better buy in the short-term than CVM.

Price Growth

CVM (@Biotechnology) experienced а +1769.82% price change this week, while MGX (@Biotechnology) price change was +10.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.82%. For the same industry, the average monthly price growth was +7.45%, and the average quarterly price growth was -1.67%.

Reported Earning Dates

CVM is expected to report earnings on May 15, 2025.

MGX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+4.82% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVM($411M) has a higher market cap than MGX($63.5M). CVM YTD gains are higher at: 1027.782 vs. MGX (-54.294). CVM has higher annual earnings (EBITDA): -22.61M vs. MGX (-65.06M). MGX has more cash in the bank: 275M vs. CVM (4.61M). CVM has less debt than MGX: CVM (11.1M) vs MGX (46.1M). MGX has higher revenues than CVM: MGX (55.1M) vs CVM (0).
CVMMGXCVM / MGX
Capitalization411M63.5M647%
EBITDA-22.61M-65.06M35%
Gain YTD1027.782-54.294-1,893%
P/E RatioN/AN/A-
Revenue055.1M-
Total Cash4.61M275M2%
Total Debt11.1M46.1M24%
FUNDAMENTALS RATINGS
CVM: Fundamental Ratings
CVM
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
49
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CVMMGX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
79%
MACD
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SCNUX11.12N/A
N/A
Invesco Income Advantage U.S. Fund Inv
AREEX26.45N/A
N/A
American Century Real Estate A
GACIX44.74N/A
N/A
Gabelli Small Cap Growth I
LGLCX39.69N/A
N/A
Lord Abbett Growth Leaders C
GEBNX10.77N/A
N/A
Goldman Sachs ESG Em Mkts Eq Inv

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-2.94%
KOD - MGX
41%
Loosely correlated
-12.93%
CVM - MGX
39%
Loosely correlated
-11.74%
VERV - MGX
38%
Loosely correlated
-8.24%
KYTX - MGX
35%
Loosely correlated
-7.53%
IMNM - MGX
34%
Loosely correlated
-7.48%
More